Evaluating the Clinical Impact of a PCP Developed Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Diabetes Mellitus, Type 2
- Sponsor
- The Reading Hospital and Medical Center
- Enrollment
- 65
- Locations
- 1
- Primary Endpoint
- Hemoglobin A1c
- Status
- Recruiting
- Last Updated
- 9 months ago
Overview
Brief Summary
The goal of this clinical trial is to evaluate the use and effectiveness of a mobile web application (app) that is designed to educate and allow patients to manage diabetes and make sustainable lifestyle changes, and to study the impact of the app on clinical outcomes of diabetes (HA1C) and educational outcomes (Self-Efficacy for Diabetes Scale). The main question to answer is: Does the use of the Diabetes Application significantly affect clinical outcomes of diabetes and cardiometabolic risk factors (BMI and Blood Pressure)? Patients will be enrolled in one of two available arms of the study.
Participants in the 'intervention arm' will use the app to view educational information presented as videos in the following areas: Healthy Coping, Healthy Eating, Staying Active, Medications (Use and Safety), Problem Solving in Diabetes and Disease Pathophysiology. They will continue routine follow-up care with their primary care physicians during the study.
Participants in the 'control arm' will continue with their primary care physician in routine follow-up care, as normally scheduled.
Researchers will compare the intervention arm participants to the control arm participants to find out about and compare changes in HA1C, systolic blood pressure, diastolic blood pressure, and body mass index. Groups will also be compared on the basis of self-perceived confidence of managing their diabetes by way of the Diabetes Self Efficacy Scale.
Investigators
Luis Murillo
Residency Faculty Associate, Director Hanna Center for Primary Care Research
The Reading Hospital and Medical Center
Eligibility Criteria
Inclusion Criteria
- •Age ≥ 18 years
- •Diagnosis of Type 2 Diabetes with HA1c \>8.0
- •Current patients of the Family Healthcare Center, Reading Hospital Tower health.
Exclusion Criteria
- •Identified special populations (pregnancy or individuals currently incarcerated)
- •Patients without access to their own smart phone
- •Any patient who is unable to provide their own informed consent to participate in the study
Outcomes
Primary Outcomes
Hemoglobin A1c
Time Frame: 6 months
Blood Test
"Self-Efficacy for Diabetes Scale"
Time Frame: 6 months
A validated (free to use) survey that examines self-perceived ability to manage diabetes. Scores are reported on a scale from 1-10. 1 reflecting Not at all confident and 10 reflecting confident. The minimum total value is 8, and the maximum value is 80. A higher score indicates that the individual has a better outcome, i.e., more confident that he/she can perform the task regularly at the present time.
Secondary Outcomes
- Body Mass Index(6 months)